Prostate Hypoxia FAZA

Official Title

A Feasibility Study of Hypoxia Imaging in Patients With Prostate Cancer Using Positron Emission Tomography (PET) With 18F-Fluoroazomycin Arabinoside (18F-FAZA)


The purpose of this study is to look for low levels of oxygen (hypoxia) in prostate cancer using a special x-ray test called a positron emission tomography (PET)scan. Hypoxia may have an effect on how prostate cancer grows and responds to treatments like radiation therapy and chemotherapy. The use of PET scans to measure hypoxia may be better and simpler than the methods used previously.

Trial Description

Primary Outcome:

  • Number of patients treated with the PET tracer FAZA to image primary tumour hypoxia in patients with prostate cancer prior to treatment with radiation therapy +/- concurrent and adjuvant hormonal therapy

View this trial on

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.


Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society